Strongyloidiasis risk factors: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Strongyloidiasis}}
{{Strongyloidiasis}}
{{CMG}} ; {{AE}} {{ADG}}
{{CMG}}; {{AE}} {{ADG}}


==Overview==
==Overview==
Line 7: Line 7:


==Risk factors==
==Risk factors==
Common risk factors in the development of strongyloidiasis include: <ref name="pmid17042927">{{cite journal |vauthors=Evering T, Weiss LM |title=The immunology of parasite infections in immunocompromised hosts |journal=Parasite Immunol. |volume=28 |issue=11 |pages=549–65 |year=2006 |pmid=17042927 |pmc=3109637 |doi=10.1111/j.1365-3024.2006.00886.x |url=}}</ref><ref name="pmid26925367">{{cite journal |vauthors=Ostera G, Blum J |title=Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States |journal=Curr Trop Med Rep |volume=3 |issue= |pages=1–3 |year=2016 |pmid=26925367 |pmc=4757600 |doi=10.1007/s40475-016-0065-3 |url=}}</ref>
Common risk factors in the development of strongyloidiasis include:<ref name="pmid17042927">{{cite journal |vauthors=Evering T, Weiss LM |title=The immunology of parasite infections in immunocompromised hosts |journal=Parasite Immunol. |volume=28 |issue=11 |pages=549–65 |year=2006 |pmid=17042927 |pmc=3109637 |doi=10.1111/j.1365-3024.2006.00886.x |url=}}</ref><ref name="pmid26925367">{{cite journal |vauthors=Ostera G, Blum J |title=Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States |journal=Curr Trop Med Rep |volume=3 |issue= |pages=1–3 |year=2016 |pmid=26925367 |pmc=4757600 |doi=10.1007/s40475-016-0065-3 |url=}}</ref>
*Occupations that increase contact with contaminated soil such as farming and coal mining
*Occupations that increase contact with contaminated soil such as farming and coal mining
*[[Human T-lymphotropic virus|human T-cell lymphotropic virus]]-1 ([[HTLV-1|HTLV]]-1) infection
*[[Human T-lymphotropic virus|Human T-cell lymphotropic virus]]-1 ([[HTLV-1|HTLV]]-1) infection
*[[Immunosuppressive therapy]] with [[corticosteroids]] and other medications,
*[[Immunosuppressive therapy]] with [[corticosteroids]] and other medications,
*[[Immune reconstitution syndrome]]
*[[Immune reconstitution syndrome]]
Line 16: Line 16:
*[[Malnutrition]]
*[[Malnutrition]]
*[[Diabetes mellitus]], [[chronic obstructive pulmonary disease]] ([[COPD]]), [[renal failure|chronic renal failure]].
*[[Diabetes mellitus]], [[chronic obstructive pulmonary disease]] ([[COPD]]), [[renal failure|chronic renal failure]].
*People living in endemic regions.
*Living in endemic regions.
*[[Alcoholism|Alcoholics]]
*[[Alcoholism|Alcoholics]]
*Travelers, immigrants
*Travelers, immigrants
Line 23: Line 23:


{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
 
[[Category:Gastroenterology]]
{{WH}}
[[Category:Dermatology]]
{{WS}}
[[Category:Neurology]]
[[Category:Pulmonology]]

Latest revision as of 00:20, 30 July 2020

Strongyloidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Strongyloidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Strongyloidiasis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Strongyloidiasis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Strongyloidiasis risk factors

CDC on Strongyloidiasis risk factors

Strongyloidiasis risk factors in the news

Blogs on Strongyloidiasis risk factors

Directions to Hospitals Treating Strongyloidiasis

Risk calculators and risk factors for Strongyloidiasis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of strongyloidiasis include immunosuppressive therapies with corticosteroids and other medications, HTLV-1 infection, organ transplantation, immune reconstitution syndrome, hematologic malignancies (especially lymphoma), tuberculosis, and malnutrition.

Risk factors

Common risk factors in the development of strongyloidiasis include:[1][2]

References

  1. Evering T, Weiss LM (2006). "The immunology of parasite infections in immunocompromised hosts". Parasite Immunol. 28 (11): 549–65. doi:10.1111/j.1365-3024.2006.00886.x. PMC 3109637. PMID 17042927.
  2. Ostera G, Blum J (2016). "Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States". Curr Trop Med Rep. 3: 1–3. doi:10.1007/s40475-016-0065-3. PMC 4757600. PMID 26925367.

Template:WH Template:WS